Headache and Migraine

 
FDA Grants First-in-Class Marketing Authorization for Digital Therapeutic in Episodic Migraine Prevention
April 16, 2025

CT-132 is a 12-week app-based intervention that uses validated behavioral techniques to modulate labile brain circuitry involved in migraine, according to Click Therapeutics.

Misdiagnosis of Migraine Drives Unnecessary Use of Health Care Resources
March 17, 2025

A new study compared health care utilization and costs between adults initially misdiagnosed followed by a correct diagnosis of migraine and those whose first diagnosis was accurate.

Elevated Suicide Risk Identified in People with Headache Disorders
February 10, 2025

Post-traumatic headaches and trigeminal autonomic cephalalgia significantly increased the risk for attempted and completed suicide, according to new study.